The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever

被引:146
作者
Gershoni-Baruch, R [1 ]
Brik, R
Zacks, N
Shinawi, M
Lidar, M
Livneh, A
机构
[1] Rambam Med Ctr, Dept Med Genet, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Chaim Sheba Med Ctr, Tel Hashomer, Israel
[4] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 04期
关键词
D O I
10.1002/art.10944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The clinical profile in familial Mediterranean fever (IMF), including its major manifestation, amyloidosis, is influenced by MEFV allelic heterogeneity and other genetic and/or environmental factors. In this study, we analyzed the contribution of genotypes at the MEFV and SAA1 loci to disease severity and to the development of amyloidosis, and further defined the factors affecting the clinical profile of IMF. Methods. We investigated a sample of 277 IMF patients (154 men and 123 women), including 62 patients with nephropathic amyloidosis, in whom both IMF alleles had been identified. A detailed chart review, interview, and physical examination were undertaken to determine the patients' demographic characteristics, medical history, clinical manifestations, and treatment. The disease severity score was calculated from the Tel-Hashomer key. Genotypes at the SAA1 locus (isoforms alpha, beta, and gamma) were determined in all patients. The SAA1 13C/T polymorphism of the SAA1 promotor was analyzed in a subset of cases. Results. The male:female ratio (154:123, or 1.3) was higher among patients with amyloidosis (40:22, or 1.8) compared with patients without amyloidosis (114:101, or 1.1). Logistic regression analysis showed that homozygosity for the M694V allele (odds ratio [OR] 4.27, 95% confidence interval [95% CI] 2.01-9.07), the presence of the SAAalpha/alpha genotype (OR 2.99, 95% CI 1.47-6.09), the occurrence of arthritis attacks (OR 2.43, 95% CI 1.17-5.06), and male sex (OR 1.73, 95% CI 0.90-3.33) were significantly and independently associated with renal amyloidosis. Disease severity was mainly influenced by MEFV mutations and was not associated with genotypes at the SAA1 locus. The SAA1 13T allele was rare, being associated mainly with the SAA gamma isoform, and not related to renal amyloidosis. Conclusion. Overall, disease severity and the development of amyloidosis in IMF are differentially affected by genetic variations within and outside the MEFV gene.
引用
收藏
页码:1149 / 1155
页数:7
相关论文
共 36 条
[1]   Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population [J].
Aksentijevich, I ;
Torosyan, Y ;
Samuels, J ;
Centola, M ;
Pras, E ;
Chae, JJ ;
Oddoux, C ;
Wood, G ;
Azzaro, MP ;
Palumbo, G ;
Giustolisi, R ;
Pras, M ;
Ostrer, H ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) :949-962
[2]   A NOVEL ALLELIC VARIANT OF SERUM AMYLOID-A, SAA1-GAMMA - GENOMIC EVIDENCE, EVOLUTION, FREQUENCY, AND IMPLICATION AS A RISK FACTOR FOR REACTIVE SYSTEMIC AA-AMYLOIDOSIS [J].
BABA, S ;
MASAGO, SA ;
TAKAHASHI, T ;
KASAMA, T ;
SUGIMURA, H ;
TSUGANE, S ;
TSUTSUI, Y ;
SHIRASAWA, H .
HUMAN MOLECULAR GENETICS, 1995, 4 (06) :1083-1087
[3]   Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF) [J].
Bernot, A ;
da Silva, C ;
Petit, JL ;
Cruaud, C ;
Caloustian, C ;
Castet, V ;
Ahmed-Arab, M ;
Dross, C ;
Dupont, M ;
Cattan, D ;
Smaoui, N ;
Dodé, C ;
Pêcheux, C ;
Nédelec, B ;
Medaxian, J ;
Rozenbaum, M ;
Rosner, I ;
Delpech, M ;
Grateau, G ;
Demaille, J ;
Weissenbach, J ;
Touitou, I .
HUMAN MOLECULAR GENETICS, 1998, 7 (08) :1317-1325
[4]   Pyrin/marenostrin mutations in familial Mediterranean fever [J].
Booth, DR ;
Gillmore, JD ;
Booth, SE ;
Pepys, MB ;
Hawkins, PN .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (09) :603-606
[5]   SAA1 alleles as risk factors in reactive systemic AA amyloidosis [J].
Booth, DR ;
Booth, SE ;
Gillmore, JD ;
Hawkins, PN ;
Pepys, MB .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1998, 5 (04) :262-265
[6]   Familial Mediterranean fever: Clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients [J].
Brik, R ;
Shinawi, M ;
Kepten, I ;
Berant, M ;
Gershoni-Baruch, R .
PEDIATRICS, 1999, 103 (05)
[7]   Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever [J].
Cazeneuve, C ;
Ajrapetyan, H ;
Papin, S ;
Roudot-Thoraval, F ;
Geneviève, D ;
Mndjoyan, E ;
Papazian, M ;
Sarkisian, A ;
Babloyan, A ;
Boissier, B ;
Duquesnoy, P ;
Kouyoumdjian, JC ;
Girodon-Boulandet, E ;
Grateau, G ;
Sarkisian, T ;
Amselem, S .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (05) :1136-1143
[8]   MEFV-gene analysis in Armenian patients with familial Mediterranean fever:: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype -: Genetic and therapeutic implications [J].
Cazeneuve, C ;
Sarkisian, T ;
Pêcheux, C ;
Dervichian, M ;
Nédelec, B ;
Reinert, P ;
Ayvazyan, A ;
Kouyoumdjian, JC ;
Ajrapetyan, H ;
Delpech, M ;
Goossens, M ;
Dodé, C ;
Grateau, G ;
Amselem, S .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :88-97
[9]  
DEBEER FC, 1982, LANCET, V2, P231
[10]   Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF) [J].
Dewalle, M ;
Domingo, C ;
Rozenbaum, M ;
Ben-Chétrit, E ;
Cattan, D ;
Bernot, A ;
Dross, C ;
Dupont, M ;
Notarnicola, C ;
Levy, M ;
Rosner, I ;
Demaille, J ;
Touitou, I .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (01) :95-97